Kefei Dou

Interventional cardiologist / Cardiologist
Fu Wai Hospital, Chinese Academy of Medical Sciences - Beijing, China

Latest contributions

New evidence for coronary revascularisation

21 May 2026 – From EuroPCR 2026

This session highlights new evidence in coronary revascularisation, including the role of CT-derived virtual stenting for procedural optimization, left ventricular unloading during complex PCI, long-term outcomes of FFR-guided PCI versus medical therapy, Impella CP support in high-risk PCI, and comparative results of PCI versus CABG in...

Choosing the right strategy for isolated ostial left anterior descending artery or circumflex coronary lesions

20 May 2026 – From EuroPCR 2026

This session examines optimal strategies for managing isolated ostial lesions in the left anterior descending and circumflex arteries, comparing left main crossover, ostial stenting, and drug-coated balloon (DCB) approaches. It emphasizes integrating multimodality imaging for informed decision-making, illustrated through detailed case discussions.

Calcified coronary: LIVE Educational Case from Clinique Pasteur - Toulouse, France

20 May 2026 – From EuroPCR 2026

This live educational case from Clinique Pasteur in Toulouse, France, showcases the management of complex calcified coronary lesions through multimodality imaging guidance. It addresses the selection of plaque modification devices and discusses optimal stenting strategies for challenging calcified bifurcation lesions, complemented by live procedural insights and...

Innovative strategies for coronary interventions

22 May 2025 – From EuroPCR 2025

Explore innovative strategies in coronary interventions, including the EPIC26 sirolimus-eluting stent study, use of percutaneous ventricular assist devices in high-risk patients, the SCORE multicenter study on SeQuent SCB, DCB versus DES for ostial left circumflex lesions, and site-specific antithrombotic therapy outcomes from the DESyne BDS Plus...

Innovative strategies for coronary interventions

PCR meets China: great innovations and novel trials

21 May 2025 – From EuroPCR 2025

Join this session to explore innovative coronary and valvular device developments originating from China. Learn about the clinical relevance and global impact of these domestic innovations, and engage in knowledge exchange with Chinese colleagues, celebrating longstanding collaboration in cardiology.

PCR meets China: great innovations and novel trials

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR

Bi-directional approach in a complex CTO - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to discuss how to plan and guide a CTO PCI, to learn how to select the most appropriate wires and microcatheters and to appraise how to apply antegrade and retrograde techniques in a structured manner.

This session was originally presented during...

Bi-directional approach in a complex CTO

Antegrade CTO PCI with wire escalation - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to discuss how to plan and guide a CTO PCI, to learn how to select the most appropriate wires and microcatheters, and to appraise how to apply antegrade and retrograde techniques in a structured manner.

This session was originally presented during...

Antegrade CTO PCI with wire escalation